AIM·00901B303·US·equity·Healthcare - Biotechnology-13D/G
AIM (AIM IMMUNOTECH INC) is held by 10 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($17,501), XTX Topco Ltd ($12,045), JANE STREET GROUP, LLC ($11,727). Net institutional sentiment: Bullish.
See how AIM's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer